Thermo Fisher Scientific Inc. (TMO) Intrinsic Value

DCF-based fair value calculation with Bear, Base, and Bull scenarios

Popular:

Thermo Fisher Scientific Inc. (TMO)

View Full Profile →

Intrinsic Value (DCF)

Current$624.65
Intrinsic$372.18
-40%
$224.92$372.18$665.21
Market implies 24% growth for 5 years
Current price reflects execution expectations above 13% growth — not unreasonable for quality businesses.
At $625, the market prices in continued strong cash flow growth (24%) — likely reflecting buybacks, margin stability, and ecosystem strength.
Range: Bear $225 → Bull $665. Current price implies expectations above the base case, closer to bull expectations.
Discount ↓Growth →9%11%13%15%
8%$478$527$579$636
10%$305$337$372$410
12%$213$237$263$290
14%$157$175$195$217

Bull Case

  • Bull case ($665) offers 6% upside at 15% growth, 8% discount
  • Conservative 13% growth assumption is achievable based on track record

Bear Case

  • Bear case ($225) implies 64% downside at 10% growth, 12% discount
  • Price reflects 24% growth expectations vs 13% historical — high bar to clear
  • Trading 40% above base case — execution must exceed assumptions to justify
Loading charts...

5-Year Free Cash Flow Projection

Year 1$8.18B
Year 2$9.20B
Year 3$10.35B
Year 4$11.64B
Year 5$13.10B
Terminal$207.58B

📐 Model Inputs

Growth Rate12.5%5Y CAGR (cascade: 5Y→3Y→TTM)
Discount Rate9.5%WACC estimate
Terminal Growth3.0%Perpetuity rate
Base Free Cash Flow$7.27BTTM actual
Bear g×0.8, r+2%
Base Historical CAGR
Bull g×1.2, r−1.5%
ℹ️

DCF estimates based on historical growth rates extrapolated forward. See FAQ below for full methodology.

Frequently Asked Questions

Is TMO stock undervalued or overvalued?
🔴 OVERVALUED

TMO trades at $624.65 vs. our DCF-derived intrinsic value of $372.18, implying -40% downside. Using a 9.5% WACC and 12.5% FCF growth assumption, the current price requires growth rates above our estimates to be justified. Even our bull case ($575.19) suggests limited upside.

What is TMO's intrinsic value?

Using a 5-year DCF model: Base FCF of $7.27B, projected at 12.5% 5Y CAGR (best of revenue, EPS, or FCF growth), discounted at 9.5% WACC, with 3.0% terminal growth. Terminal value calculated via Gordon Growth Model: TV = FCF₅ × (1+g) / (WACC−g). After deducting $28.76B net debt and dividing by 0.38B shares: Bear $230.96 | Base $372.18 | Bull $575.19. Current price $624.65 implies -40% to base case.

How is TMO's fair value calculated?

DCF Methodology:

① Project FCF years 1-5 using 12.5% growth derived from 5-year historical CAGR (best of revenue, EPS, or FCF growth, with 8% floor and 25% cap).

② Calculate terminal value at year 5 using perpetuity growth model with g=3.0%.

③ Discount all cash flows to PV using WACC=9.5%.

④ Sum PV of explicit period + PV of terminal value = Enterprise Value ($171.30B).

⑤ Subtract net debt, divide by shares outstanding.

Sensitivity analysis available above—adjust WACC ±2% or growth ±3% to stress-test the valuation. Implied EV/FCF multiple: 23.6x.